Clinical outcomes and management of mechanism-based inhibition of cytochrome P450 3A4.

Authors:
Zhou S; Chan E; Li X; Huang M.

Journal:
Ther Clin Risk Manag

Publication Year: 2005

PMCID:
PMC1661603

PMID:
18360537

View on PubMed View on PMC
Journal Information

Full Title: Ther Clin Risk Manag

Abbreviation: Ther Clin Risk Manag

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Health Care Sciences & Services

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Acthar Gel in African Americans versus Non-African Americans with Symptomatic Sarcoidosis: Physicia…
Bindra J; Chopra I; Hayes K and 3 more (2024) - Transparency Score: 3/6
Classification and Regression Tree Predictive Model for Acute Kidney Injury in Traumatic Brain Inju…
Wang R; Zhang J; He M and 1 more (2024) - Transparency Score: 3/6
Factors Influencing the Fasting Time in Adult Patients After the Endoscopic Management of Sharp Eso…
Wu DQ; Chen SY; Chen KG and 3 more (2024) - Transparency Score: 3/6
Profile of Sofosbuvir and Velpatasvir Combination in the Treatment of Chronic Hepatitis C in Childr…
Brigham D; Narkewicz MR. (2024) - Transparency Score: 2/6
Risk Factors of Chylothorax After Congenital Heart Surgery in Infants: A Single-Centre Retrospectiv…
Zhang RG; Liu YM; Yao ZY and 9 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"The authors appreciate the support by the National University of Singapore Academic Research Funds."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025